SCHEMBL27034883

SCHEMBL27034883

O=C(O)c1c[nH]c2c(F)c(F)cc(F)c12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A2 P19784 2/20 0.41
▸ CSNK2B P67870 2/20 0.41
▸ CSNK2A1 P68400 2/20 0.41
▸ PRKAG1 P54619 13/20 0.39
▸ PRKAA1 Q13131 13/20 0.39
▸ PRKAB1 Q9Y478 13/20 0.39
▸ PRKAA2 P54646 12/20 0.39
▸ PRKAB2 O43741 11/20 0.39
▸ PRKAG3 Q9UGI9 11/20 0.39
▸ PRKAG2 Q9UGJ0 11/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ NOTUM Q6P988 1/20 0.34
▸ F7 P08709 1/20 0.34
▸ F3 P13726 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16597462 0.79 CSNK2A2 (0.40) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL12748348 0.72 CSNK2A2 (0.60) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL1275907 0.72 ADRA2A (0.50) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL16597426 0.72 CYP1A2 (0.39) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL10508264 0.71 CSNK2A1 (0.51) CSNK2A2CSNK2BCSNK2A1KDM4ECYP1A2
SCHEMBL25331893 0.71 PRKAG1 (0.50) PRKAG1PRKAA1PRKAB1PRKAA2PRKAB2
SCHEMBL14037111 0.71 CSNK2A1 (0.39) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL1878010 0.71 KDM4E (0.51) CSNK2A2CSNK2BCSNK2A1KDM4ECYP1A2
SCHEMBL2576855 0.69 ALDH1A1 (0.54) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1
SCHEMBL12748345 0.69 CSNK2A2 (0.52) CSNK2A2CSNK2BCSNK2A1PRKAG1PRKAA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118146228-A Deuterated spiro compound crystal form and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-07 — — CN disclosed
WO-2024017270-A1 SPIRO COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 深圳信立泰药业股份有限公司 2024-01-25 — — WO disclosed
CN-116621918-B Spiro compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2023-10-31 — — CN disclosed
CN-116621918-A Spiro compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2023-08-22 — — CN disclosed
Send feedback